Active immunization induces lung hyperresponsiveness in the guinea pig. Pharmacologic modulation and triggering role of the booster injection
- PMID: 3202509
- DOI: 10.1164/ajrccm/138.6.1572
Active immunization induces lung hyperresponsiveness in the guinea pig. Pharmacologic modulation and triggering role of the booster injection
Abstract
In order to investigate whether bronchopulmonary hyperresponsiveness represents a unique property of sensitized lungs, we examined the responses of lungs from either actively sensitized, passively sensitized, or nonsensitized (control) guinea pigs to in vitro bronchoconstriction (BC) and release of thromboxane (TX) B2, 6-keto-PGF1 alpha, and histamine induced by platelet-activating factor (PAF-acether) or leukotriene (LT) D4. Guinea pigs were actively sensitized with 10 micrograms of either ovalbumin or Dermatophagoides farinae extract in AI(OH)3 injected intraperitoneally twice at a 2-wk interval. Seven days after the second injection (booster injection), the lungs were removed, ventilated, and perfused via the pulmonary artery with Krebs solution containing 2.5 g/L bovine serum albumin. In lungs from actively sensitized animals, BC was induced by significantly lower doses of PAF-acether and LTD4 than those required to elicit the same response in control preparations. In addition, sensitized lungs released more TxB2, 6-keto-PGF1 alpha, and histamine in response to PAF-acether and LTD4 than did control lungs. Increased mediator release was also observed upon challenge of lungs from actively sensitized animals with arachidonic acid and histamine. Lungs from guinea pigs passively sensitized with serum from actively sensitized animals did not exhibit increased responsiveness to PAF-acether as compared to control lungs. The hyperresponsiveness induced after booster injection of the antigen occurred concomitantly with an increase in the homocytotropic antibody titer (as measured by passive cutaneous anaphylaxis) and persisted for 3 months after sensitization, when the levels of circulating antibodies and lung response to antigen challenge returned to control values.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Role of lipoxygenase metabolites for the hyper-responsiveness to platelet-activating factor of lungs from actively sensitized guinea pigs.J Pharmacol Exp Ther. 1989 Jan;248(1):353-9. J Pharmacol Exp Ther. 1989. PMID: 2464060
-
Protection by nedocromil sodium of active immunization-induced bronchopulmonary alterations in the guinea pig.Am Rev Respir Dis. 1990 May;141(5 Pt 1):1259-65. doi: 10.1164/ajrccm/141.5_Pt_1.1259. Am Rev Respir Dis. 1990. PMID: 2160213
-
Inhibition by azelastine of the effects of platelet-activating factor in lungs from actively sensitised guinea-pigs.Eur J Pharmacol. 1992 Jun 5;216(2):141-7. doi: 10.1016/0014-2999(92)90354-7. Eur J Pharmacol. 1992. PMID: 1397002
-
Platelet-activating factor (PAF) and PAF antagonists in asthma.Crit Rev Ther Drug Carrier Syst. 1990;7(3):261-73. Crit Rev Ther Drug Carrier Syst. 1990. PMID: 2073689 Review.
-
PAF-acether and experimental anaphylaxis as a model for asthma.Int Arch Allergy Appl Immunol. 1989;88(1-2):149-53. doi: 10.1159/000234770. Int Arch Allergy Appl Immunol. 1989. PMID: 2540093 Review.
Cited by
-
Lipopolysaccharide from Escherichia coli reduces antigen-induced bronchoconstriction in actively sensitized guinea pigs.J Clin Invest. 1991 Jun;87(6):1936-44. doi: 10.1172/JCI115219. J Clin Invest. 1991. PMID: 2040687 Free PMC article.
-
Interference of BN 52021, an antagonist of PAF, with different forms of active anaphylaxis in the guinea-pig: importance of the booster injection.Br J Pharmacol. 1991 Mar;102(3):687-95. doi: 10.1111/j.1476-5381.1991.tb12234.x. Br J Pharmacol. 1991. PMID: 1285397 Free PMC article.
-
Prevention of antigen-induced bronchial hyperreactivity and airway inflammation in sensitized guinea-pigs by tacrolimus.Mediators Inflamm. 1999;8(1):17-23. doi: 10.1080/09629359990676. Mediators Inflamm. 1999. PMID: 10704085 Free PMC article.
-
Proceedings of the British Pharmacological Society Meeting. 3rd-5th January 1990. Abstracts.Br J Pharmacol. 1990 Apr;99 Suppl(Suppl):1P-302P. Br J Pharmacol. 1990. PMID: 2317620 Free PMC article. No abstract available.
-
The booster injection of antigen during active sensitization of guinea-pig modifies the anti-anaphylactic activity of the PAF antagonist WEB 2086.Br J Pharmacol. 1990 Jun;100(2):217-22. doi: 10.1111/j.1476-5381.1990.tb15785.x. Br J Pharmacol. 1990. PMID: 2379029 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical